Nanotechnology in Drug Delivery Market Size 2021 By Share, Industry Statistics, Trends Evaluation, Business Challenges and Investment Opportunities Analysis till 2027
Global Nanotechnology
in Drug Delivery Market is expected to reach the market valuation of US$ 182.3
billion by 2027 expanding at a reasonable CAGR of 19.9% during the forecast
period (2021-2027) from US$ 44 billion in 2019. Nanotechnology is utilized in
targeted drug delivery at the site of disease to expand the uptake of poorly
soluble drugs, the targeting of drugs to a precise site, and drug
bioavailability.
The various factors driving the Nanotechnology
in Drug Delivery market include the increasing necessity for alternative
approaches to conventional chemotherapy generates prospects for nanoparticles, the
need for developing new and improved drug and gene delivery methods, and increasing
prevalence of chronic diseases and illnesses like cancer and cardiovascular
diseases. However, the transition from microparticles to nanoparticles leading
to problems like interarticular friction and research and development of
nanomaterials for drug delivery in large scale production is expected to hinder
the growth of the Nanotechnology in Drug Delivery market.
Request
for Sample of the report browse through - https://univdatos.com/request_form/form/355
Amid the COVID-19
pandemic, the nanotechnology tools gave great utility across numerous routes
ranging from viral neutralization and identification to vaccine production and
treatment. While considering that SARS-CoV-2 has nanometric dimensions with a
core-shell nanostructure, nanotechnology comes into play and could therefore be
considered as an afunctional nanomaterial. Nanocarriers also have the potential
to design risk-free and effective immunization strategies for SARS-CoV-2
vaccine candidates such as protein constructs and nucleic acids. A study performed by Leuschner et al. brings
a direction in the use of nanotechnology to control the cytokine storm which is
amongst few clinical complications of COVID-19.
Based on technology, the market is
fragmented into nanoparticles,
liposomes, nanocrystals, micelles, and others. The nanoparticles
segment dominated the market in 2019 and generated total revenue of US$ 12
billion. It is anticipated to maintain its dominance during the forecast period
owing to the easily modified and functionalized surface
of nanoparticles which increases the specificity of therapeutic agents in the targeted
tissue. However, the micelles segment is expected to witness the highest CAGR growth during
the forecast period.
For a
detailed analysis of the technology in Nanotechnology in Drug Delivery Market browse
through https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market-current-analysis-and-forecast-2020-2027
Nanotechnology in Drug Delivery holds potential in various applications
including oncology, cardiovascular/physiology, anti-inflammatory/ immunology,
neurology, anti-infective, and others. The oncology segment dominated the market and generated revenue of US$ 15.9
billion in 2019 owing to the increasing number of cancer cases. In 2018, Cancer
was amongst the top leading cause of death worldwide, with an estimated 9.6
million deaths, or 1 in 6 deaths.
Additionally, the report provides detailed
initiatives that are being taken in the field of Nanotechnology in Drug
Delivery. The market is classified into distinct regions North
America (United States, Canada, and the Rest of North America), Europe
(Germany, France, Italy, Spain, United Kingdom and Rest of Europe),
Asia-Pacific (China, Japan, Australia, South Korea, India, and Rest of APAC),
Rest of World has been conducted. North America dominated the market and
generated revenue of US$ 18.9 billion in 2019 owing to the increasing prevalence rate of cancer, presence of high disposable
income, and rise in funding for R&D activities associated with
Nanotechnology in Drug Delivery. Cancer is the leading cause of death in Canada
and the second-leading cause, after heart disease, in the USA. Nearly 1.9
million new cancer cases and 693,000 cancer deaths were estimated in North
America in 2018.
For a
detailed analysis of the COVID-19 Impact on Nanotechnology in Drug Delivery Market
browse through https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market-current-analysis-and-forecast-2020-2027
Camarus AB, Nanobiotix, NanoCarrier Co., Ltd.,
Selecta Biosciences, Starpharma Holdings Limited, Taiwan Liposome Co., Pfizer, Novartis,
Merck & Co., and Bayer are some of the prominent players
operating in the global Nanotechnology in Drug Delivery market. Several M&A’s along with partnerships have been undertaken by
these players to develop Nanotechnology in Drug Delivery.
Global Nanotechnology in Drug
Delivery Market
Segmentation
Market Insight, by Technology
· Nanoparticles
· Liposomes
· Nanocrystals
· Micelles
· Others
Market Insight, by Application
· Oncology
· Cardiovascular/
Physiology
· Anti-inflammatory/
Immunology
· Neurology
· Anti-infective
· Others
Market Insight, by Region
·
North America
o
United States
o
Canada
o
Rest of North America
·
Europe
o
France
o
Germany
o
Italy
o
Spain
o
United Kingdom
o
Rest of Europe
·
Asia-Pacific
o
China
o
Japan
o
Australia
o
South Korea
o
India
o
Rest of Asia-Pacific
·
Rest of World
Top Company Profiles
· Camarus AB
· Taiwan Liposome Co.
· Novartis
· Nanobiotix
· NanoCarrier Co., Ltd.
· Bayer
· Selecta Biosciences
· Pfizer
· Starpharma Holdings Limited
· Merck & Co.
The Nanotechnology
in Drug Delivery Market can further be customized as per the
requirement or any other market segment. Besides this, UMI understands that you
may have your own business needs, hence feel free to connect with us to get a
report that completely suits your requirements.
Comments